TerSera Co-pay Assistance
TerSera
TerSera offers co-pay assistance for the prescription medication Xermelo (telotristat ethyl). This program is designed for adults with carcinoid syndrome diarrhea who are using Xermelo along with somatostatin analog (SSA) therapy, especially when their condition is not adequately controlled by SSA therapy alone.
- Covers
- financial assistance
- Max income (FPL)
- 500%
- Max award
- $15,000
- Enrollment cycle
- unknown
Eligibility
The HealthWell Foundation Neuroendocrine Tumors Fund provides up to $15,000 in medication copayment or insurance premium assistance to underinsured Americans living with neuroendocrine tumors. Eligible applicants must have household incomes up to 500 percent of the federal poverty level.
Apply
Application goes directly to TerSera. RxCopays does not receive compensation.
Go to application →Status source
TerSera offers co-pay assistance for Xermelo (telotristat ethyl)
Rare-disease support beyond financial help
This grant covers a rare condition. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: